Phosphodiesterase type 5 inhibitors: discovery and therapeutic utility

被引：21

作者：

Rotella, DP ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA

来源：

DRUGS OF THE FUTURE | 2001年 / 26卷 / 02期

关键词：

D O I：

10.1358/dof.2001.026.02.658842

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：153 / 162

页数：10

共 43 条

[1] Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity [J].

Ahn, HS ;

Bercovici, A ;

Boykow, G ;

Bronnenkant, A ;

Chackalamannil, S ;

Chow, J ;

Cleven, R ;

Cook, J ;

Czarniecki, M ;

Domalski, C ;

Fawzi, A ;

Green, M ;

Gundes, A ;

Ho, G ;

Laudicina, M ;

Lindo, N ;

Ma, K ;

Manna, M ;

McKittrick, B ;

Mirzai, B ;

Nechuta, T ;

Neustadt, B ;

Puchalski, C ;

Pula, K ;

Silverman, L ;

Smith, E ;

Stamford, A ;

Tedesco, RP ;

Tsai, HG ;

Tulshian, D ;

Vaccaro, H ;

Watkins, RW ;

Weng, XY ;

Witkowski, JT ;

Xia, Y ;

Zhang, HT .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (14) :2196-2210

[2]

ANGLIN G, 2000, INT J IMPOT RES S3, V12

[3] CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES - FUNCTIONAL IMPLICATIONS OF MULTIPLE ISOFORMS [J].

BEAVO, JA .

PHYSIOLOGICAL REVIEWS, 1995, 75 (04) :725-748

[4]

BELL AS, Patent No. 5426107

[5]

BELL AS, Patent No. [0526004, 526004]

[6]

BENET AE, 1995, UROL CLIN N AM, V22, P699

[7]

BISCHOFF E, 2000, INT J IMPOT RES S3, V12

[8]

BUNNAGE ME, Patent No. 9849166

[9]

BUNNAGE ME, Patent No. 0995751

[10] Cyclic GMP phosphodiesterase-5: Target of sildenafil [J].

Corbin, JD ;

Francis, SH .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (20) :13729-13732

← 1 2 3 4 5 →